These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Nonalcoholic steatohepatitis: pathogenesis and treatment]. Park SH Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854 [TBL] [Abstract][Full Text] [Related]
10. The epidemiology, pathogenesis and histopathology of fatty liver disease. Levene AP; Goldin RD Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457 [TBL] [Abstract][Full Text] [Related]
11. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. Tilg H; Moschen A Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253 [TBL] [Abstract][Full Text] [Related]
12. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Cusi K Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434 [TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Musso G; Gambino R; Cassader M Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871 [TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease. Leclercq I Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266 [TBL] [Abstract][Full Text] [Related]